Abstract

This report summarizes the clinical features and the indications for treating HCV infection in immunocompromised and transplanted patients in the Direct Acting Antiviral drugs era.

Original languageEnglish
Pages (from-to)10-23
Number of pages14
JournalDigestive and Liver Disease
Volume51
Issue number1
DOIs
Publication statusPublished - Jan 1 2019

    Fingerprint

Keywords

  • HCV
  • Immunocompromised patients
  • Organ transplant

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this